Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness.
Paul Shekelle, Sydne J Newberry, Suzanne Morton(American Society for Nutrition), Lara Jungvig, Matthew A. Gubens(University of California, San Francisco), Eliane Roth, Wanxin Tu, Marco Maglione, Paul A. Heidenreich(Palo Alto University), Maarten J. Suttorp(St. Antonius Ziekenhuis), Simon J. Atkinson
PubMed
July 1, 2003
Cited by 27
Related Papers
Forecasting the Future of Cardiovascular Disease in the United States
|Circulation|2011|3.2k
Forecasting the Impact of Heart Failure in the United States
|Circulation Heart Failure|2013|2.8k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
|Journal of the American College of Cardiology|2018|2.6k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
|Journal of the American College of Cardiology|2018|1.7k